Omega Healthcare Invts (NYSE:OHI) has been the subject of varying opinions from 5 analysts over the past three months, with recent ratings showing 1 bullish and 3 indifferent stances. The average 12-month price target is now $33.00, down from $34.00, with a high estimate of $36.00 and a low of $31.00. Analysts from Deutsche Bank, B of A Securities, Mizuho, Truist Securities, and Wells Fargo have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Omega Healthcare Investors Inc is a REIT focusing on long-term healthcare facilities, aiming to grow through M&A and maintain high care standards. The company has shown a revenue growth rate of 1.09% as of September 30, 2023, a net margin of 37.76%, an ROE of 2.51%, an ROA of 0.97%, and a debt-to-equity ratio of 1.44.